Based on the comprehensive data I've gathered, here's what I found for DHR:
Danaher Corporation - Life Sciences Tools and Services sector
Price & Performance:
Short Interest Data:
Notable Short Interest Trend: DHR experienced a significant spike in short interest starting April 10th, jumping from 4.44M shares (0.70% of FF) to 6.87M shares (1.09% of FF) - a ~54% increase. The short position has remained elevated since then, though it's still relatively low in absolute terms.
ORTEX Stock Scores:
Options Sentiment:
Analyst Coverage:
Technical Indicators:
Next Event: Q1 2026 earnings scheduled for May 5, 2026
DHR shows a very clean short interest profile despite the recent uptick. The cost to borrow remains minimal (0.39%), utilization is negligible (0.13%), and shares are abundantly available. This suggests short sellers face no friction if they want to exit positions.
The recent jump in short interest from ~0.70% to 1.13% is notable but still keeps DHR well below concerning levels. For context, stocks with SI above 10-15% of free float typically garner attention for potential squeeze dynamics.
The stock's strong ORTEX Total Score of 77.36 combined with 30% analyst upside suggests fundamentals remain solid despite the YTD decline of 15%. The neutral RSI and balanced options sentiment indicate no extreme positioning either way.
With earnings coming up on May 5th, that could be a catalyst for movement in either direction.
Remember, this is not financial advice. Always do your own research before making investment decisions.
See the live data behind this article on ORTEX.
Open DHR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
